Morgan Stanley Has Lowered Expectations for CG Oncology (NASDAQ:CGON) Stock Price
CG Oncology (NASDAQ:CGON – Get Free Report) had its price objective dropped by investment analysts at Morgan Stanley from $55.00 to $52.00 in a report released on Monday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Morgan Stanley’s price target indicates a potential upside of 95.78% from the stock’s current price. A […]
CG Oncology (NASDAQ:CGON – Get Free Report) had its price objective dropped by investment analysts at Morgan Stanley from $55.00 to $52.00 in a report released on Monday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Morgan Stanley’s price target indicates a potential upside of 95.78% from the stock’s current price. A […]
